Matrix metallopeptidase 9 and placental growth factor may correlate with collateral status based on whole-brain perfusion combined with multiphase computed tomography angiography

References

• Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12(11):1106–1114.
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Wong KS, Bae HJ, et al. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396–2399.
   PubMed Web of Science ®Google Scholar
• Liebeskind DS, Cotsonis GA, Saver JL, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011;69:963–974.
   PubMed Web of Science ®Google Scholar
• Bang OY, Goyal M, Liebeskind DS. Collateral circulation in ischemic stroke: assessment tools and therapeutic strategies. Stroke. 2015;46:3302–3309.
   PubMed Web of Science ®Google Scholar
• Lin L, Yang J, Chen C, et al. Association of collateral status and ischemic core growth in patients with acute ischemic stroke. Neurology. 2020;96:e161–e170.
   Google Scholar
• Leng X, Fang H, Leung TW, et al. Impact of collateral status on successful revascularization in endovascular treatment: a systematic review and meta-analysis. Cerebrovasc Dis. 2016;41:27–34.
   PubMed Web of Science ®Google Scholar
• Shuaib A, Butcher K, Mohammad AA, et al. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol. 2011;10:909–921.
   PubMed Web of Science ®Google Scholar
• Arsava EM, Vural A, Akpinar E, et al. The detrimental effect of aging on leptomeningeal collaterals in ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23:421–426.
   PubMed Web of Science ®Google Scholar
• Menon BK, Smith EE, Coutts SB, et al. Leptomeningeal collaterals are associated with modifiable metabolic risk factors. Ann Neurol. 2013;74:241–248.
   PubMed Web of Science ®Google Scholar
• Nannoni S, Sirimarco G, Cereda CW, et al. Determining factors of better leptomeningeal collaterals: a study of 857 consecutive acute ischemic stroke patients. J Neurol. 2019;266:582–588.
   PubMed Web of Science ®Google Scholar
• Huang M, Zheng J, Chen Z, et al. The relationship between circulating neuregulin-1 and coronary collateral circulation in patients with coronary artery disease. Int Heart J. 2020;61:115–120.
   PubMed Web of Science ®Google Scholar
• Qin Q, Qian J, Ma J, et al. Relationship between thrombospondin-1, endostatin, angiopoietin-2, and coronary collateral development in patients with chronic total occlusion. Medicine (Baltimore). 2016;95:e4524.
   PubMed Web of Science ®Google Scholar
• Akboga MK, Yalcin R, Sahinarslan A, et al. Effect of serum ykl-40 on coronary collateral development and syntax score in stable coronary artery disease. Int J Cardiol. 2016;224:323–327.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Kappelle LJ, Biller J, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
   PubMed Web of Science ®Google Scholar
• Owen B, Samuels GJJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643–646.
   PubMed Web of Science ®Google Scholar
• North American Symptomatic Carotid Endarterectomy Trial Collaborators BH; Taylor DW, Haynes RB, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Son JP, Kim SJ, et al. Predicting collateral status with magnetic resonance perfusion parameters: probabilistic approach with a tmax-derived prediction model. Stroke. 2015;46:2800–2807.
   PubMed Web of Science ®Google Scholar
• Menon BK, Qazi EM, Almekhlafi M, et al. Multiphase ct angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology. 2015;275:510–520.
   PubMed Web of Science ®Google Scholar
• Galis ZSKJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90:251–262.
   PubMed Web of Science ®Google Scholar
• Cai Z, Xu T, Xu T, et al. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology. 2017;89:805–812.
   PubMed Web of Science ®Google Scholar
• Mechtouff L, Bochaton T, Paccalet A, et al. Matrix metalloproteinase-9 relationship with infarct growth and hemorrhagic transformation in the era of thrombectomy. Front Neurol. 2020;11:473.
   PubMed Web of Science ®Google Scholar
• Mechtouff L, Bochaton T, Paccalet A, et al. Matrix metalloproteinase-9 and monocyte chemoattractant protein-1 are associated with collateral status in acute ischemic stroke with large vessel occlusion. Stroke. 2020;51:2232–2235.
   PubMed Web of Science ®Google Scholar
• Abdelnaseer MM, Elfauomy NM, Esmail EH, et al. Matrix metalloproteinase-9 and recovery of acute ischemic stroke. J Stroke Cerebrovasc Dis. 2017;26:733–740.
   PubMed Web of Science ®Google Scholar
• Rosell A, Lo EH. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol. 2008;8:82–89.
   PubMed Web of Science ®Google Scholar
• Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000;2:737–744.
   PubMed Web of Science ®Google Scholar
• Collison J. Placental growth factor links angiogenesis and autoimmunity. Nat Rev Rheumatol. 2019;15:575.
   PubMed Web of Science ®Google Scholar
• Luna RL, Kay VR, Ratsep MT, et al. Placental growth factor deficiency is associated with impaired cerebral vascular development in mice. Mol Hum Reprod. 2016;22:130–142.
   PubMed Web of Science ®Google Scholar
• Kay VR, Ratsep MT, Cahill LS, et al. Effects of placental growth factor deficiency on behavior, neuroanatomy, and cerebrovasculature of mice. Physiol Genomics. 2018;50:862–875.
   PubMed Web of Science ®Google Scholar
• Bn E, Fink E, Seitz R, et al. The hyaluronan-binding serine protease from human plasma cleaves hmw and lmw kininogen and releases bradykinin. Biol Chem. 2002;383:1633–1643.
   PubMed Web of Science ®Google Scholar
• H Ih F, Kashiwagi S, Nomura S, et al. Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation. J Neurol Neurosurg Psychiatry. 1995;59:388–394.
   PubMed Web of Science ®Google Scholar
• Ling L, Hou Q, Xing S, et al. Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats. Brain Res. 2008;1206:89–97.
   PubMed Web of Science ®Google Scholar
• Li J, Chen Y, Zhang X, et al. Human urinary kallidinogenase improves outcome of stroke patients by shortening mean transit time of perfusion magnetic resonance imaging. J Stroke Cerebrovasc Dis. 2015;24:1730–1737.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang B, Zhang Y, et al. Efficacy and safety of human urinary kallidinogenase for acute ischemic stroke: a meta-analysis. J Int Med Res. 2020;48:300060520943452.
   PubMed Web of Science ®Google Scholar
• Qian Y, Lyu Y, Jiang M, et al. Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke. Brain Behav. 2019;9:e01438.
   PubMed Web of Science ®Google Scholar
• W Km M, Hirono S, Ito M, et al. Angiopoietin-1, angiopoietin-2 and tie-2 in the coronary circulation of patients with and without coronary collateral vessels. Circ J. 2007;71:343–347.
   PubMed Web of Science ®Google Scholar
• Okyere B, Mills WA 3rd, Wang X, et al. Epha4/tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke. J Clin Invest. 2020;130:1024–1035.
   PubMed Web of Science ®Google Scholar